Misonix.jpg
Misonix Receives Health Canada Approval for neXus
March 04, 2021 09:25 ET | MISONIX, Inc.
FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix.jpg
Misonix to Participate in Upcoming March Investor Conferences
March 01, 2021 08:07 ET | MISONIX, Inc.
FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix.jpg
Misonix to Participate at Upcoming Investor Conferences
February 11, 2021 10:00 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix.jpg
Misonix Announces the Second Largest U.S. Commercial Payer Has Provided Coverage for TheraSkin® to Treat All Lower Extremity Dermal Wounds Adding 32 Million New Covered Lives
December 18, 2020 10:14 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that...
Misonix.jpg
Misonix to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 23, 2020 10:00 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix.jpg
Misonix to Participate at Upcoming Craig-Hallum and Canaccord Genuity Investor Conferences
November 12, 2020 10:00 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix.jpg
Misonix to Present at the 40th Annual Canaccord Genuity Growth Conference
July 30, 2020 08:01 ET | MISONIX, Inc.
FARMINGDALE, N.Y., July 30, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix.jpg
Misonix Reports Preliminary Fiscal 2020 Fourth Quarter Revenue of Approximately $13.5 Million
July 10, 2020 07:00 ET | MISONIX, Inc.
Full Year Revenue of Approximately $62.3 Million Company Focus on Shareholder Value Creation, Cash Preservation, Expense Reduction, Workforce Efficiency and Operational Synergies FARMINGDALE,...
Misonix.jpg
Misonix to Present at the 17th Annual Craig Hallum Institutional Investor Conference On May 27
May 22, 2020 13:00 ET | MISONIX, Inc.
FARMINGDALE, N.Y., May 22, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
misonix.jpg
Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 Million
January 13, 2020 08:05 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...